...Great. Thank you, Andrew. Really appreciate it. Thanks, everyone, for joining us. We've gone towards the end of our first day of our Oppenheimer Healthcare Conference. We got Sarepta Therapeutics. And the CEO and the CFO of the company, Doug Ingram and Ian Estepan joining us today. This is a company that we've gotten very bullish on recently, and part of that is just the tremendous amount of work the company has been doing in muscular dystrophies over the last 3, 4 years. Work that is really becoming very fulsome. So we're excited to have both Doug and Ian on here to talk about the company and all the projects ongoing. So with that, welcome, gentlemen. Douglas S. Ingram ...